Tamiflu recall

The Committee reported on Tamiflu in January this year, drawing attention to the lack of transparency over the results of clinical trials of the antiviral medicine, stockpiled for use in an influenza epidemic. The Committee concluded that the failure of manufacturers to share the full results of clinical trials with doctors, researchers and clinicians, undermines …